Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $29.86 in the prior trading day, TG Therapeutics Inc (NASDAQ: TGTX) closed at $29.14, down -2.41%. In other words, the price has decreased by -$2.41 from its previous closing price. On the day, 2.08 million shares were traded. TGTX stock price reached its highest trading level at $29.9 during the session, while it also had its lowest trading level at $28.835.
Ratios:
Our goal is to gain a better understanding of TGTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 4.59. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.
On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 03 ’25 when Power Sean A sold 11,337 shares for $30.29 per share. The transaction valued at 343,443 led to the insider holds 670,632 shares of the business.
Power Sean A sold 10,021 shares of TGTX for $285,939 on Jan 06 ’25. The CFO now owns 660,611 shares after completing the transaction at $28.53 per share. On Jan 06 ’25, another insider, Power Sean A, who serves as the Officer of the company, bought 10,021 shares for $28.53 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 4536077824 and an Enterprise Value of 4095428352. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.13 while its Price-to-Book (P/B) ratio in mrq is 23.62. Its current Enterprise Value per Revenue stands at 15.467 whereas that against EBITDA is -10037.815.
Stock Price History:
The Beta on a monthly basis for TGTX is 2.25, which has changed by 0.82352936 over the last 52 weeks, in comparison to a change of 0.24359846 over the same period for the S&P500. Over the past 52 weeks, TGTX has reached a high of $36.84, while it has fallen to a 52-week low of $12.84. The 50-Day Moving Average of the stock is -7.55%, while the 200-Day Moving Average is calculated to be 27.76%.
Shares Statistics:
The stock has traded on average 3.01M shares per day over the past 3-months and 2905430 shares per day over the last 10 days, according to various share statistics. A total of 155.78M shares are outstanding, with a floating share count of 140.52M. Insiders hold about 9.73% of the company’s shares, while institutions hold 65.77% stake in the company. Shares short for TGTX as of 1735603200 were 25989480 with a Short Ratio of 8.64, compared to 1732838400 on 29081767. Therefore, it implies a Short% of Shares Outstanding of 25989480 and a Short% of Float of 18.450001.
